Patients with cardiac amyloidosis have very poor survival without therapy. Diagnosis at early stages of the disease is crucial and there are many diagnostic tools for cardiac amyloidosis.

It eventually led to Still being diagnosed with ATTR amyloidosis, a rare genetic condition that causes heart problems, neuropathy, and ligament and tendon troubles. Since his diagnosis in ...

Definite diagnosis is based on endomyocardial biopsy and treatment of cardiac amyloidosis is a challenge. Heart transplantation, although controversial, has demonstrated survival benefit.

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

Researchers from Osaka University find that peristaltic pump action and high shear flow forces promote amyloid nucleation.

Here are nine ways to get you started. Amyloidosis can cause fatigue and weakness, so the last thing you may want to do is exercise. Plus, cardiac issues can make intense workouts out of the question.

This causes the release of cardiac proteins such as troponin into the bloodstream. Read more about how raised troponin levels can indicate heart damage. Transthyretin amyloid cardiomyopathy ...

They hope this discovery will pave the way for earlier diagnosis and ... structures are associated with Alzheimer’s disease: amyloid-beta plaques and neurofibrillary tangles (NFTs).

The company is preparing for the commercial launch of bertimimab, aimed at treating AL amyloidosis, a rare and serious condition. Prothena's focus on rare diseases and neurodegenerative treatments ...

The company is preparing for the commercial launch of bertimimab, aimed at treating AL amyloidosis, a rare and serious condition. Prothena's focus on rare diseases and neurodegenerative treatments ...

Medicare payments to physician practices have decreased 33% since 2001, when adjusted for inflation, according to the American Medical Association. Ten members of the House have introduced a bill ...

“Echocardiographic evaluation using RASI may contribute to expanding the accuracy of cardiac amyloidosis subtype identification by increasing pre-test probability,” the authors wrote. “Although the ...